Our Twitter Page Our Facebook Page Site Logo
June 18th, 2013 @ 10:24

Credit Review Office: Raise Appeals Ceiling to €3 Million Now

 

 

Chambers Ireland has welcomed the 11th report of the Credit Review Office (CRO) showing that since 2010, upheld appeals have resulted in €16.8 million credit being made available to SMEs and farms, protecting 1,297 jobs.

Speaking this morning Ian Talbot, Chambers Ireland Chief Executive said, “244 cases have now been completed by the CRO with 135 of those decisions in favour of the borrower. While this is still a very small number of applications, it highlights the role that the CRO can play in processing credit decision appeals. More businesses need to use this avenue to appeal a decision that they do not agree with.”

“One positive trend over the last two quarters is an increase in credit appeals for expansion working capital and for potential investments in fixed assets to grow businesses in response to improving confidence in the economy. All confidence building measures are to be supported, in particular Mr. Trethowan’s request for the limit of appeals to be raised from €500k to €3m. This would be of significant benefit to SMEs particularly those looking to refinance debt from institutions that are in wind down mode.”

“As with previous reports, evidence suggests that the pillar banks are largely supportive of medium and low risk new lending proposals. We must ensure that credit is available to all viable SMEs and as such it is vital that issues such as response times and front line experience of banking personnel must continue to be addressed,” he continued.

“Finally, Chambers Ireland will continue to encourage members who have a query on a Pillar Bank lending decision to undertake the full appeals process,” Talbot concluded.

Tags: Categories: Business News

Site Search

Featured Member

Allergan

 

Allergan was established in Westport in 1977 and has repeatedly expanded over the last four decades, contributing significantly to the local economy.

The Westport facility is now the largest manufacturing plant within the company network, and it also has the largest number of Allergan staff in one location, outside of the company’s corporate headquarters.

In Ireland, our focus fosters deep engagement with medical specialists and we make it our business to listen closely to their needs so that together we can advance patient care. We combine this strategic focus with a diversified approach that enables us to follow our research and development into new specialty areas where unmet needs are significant.

In partnership with the medical community, we bring scientific excellence and rigour to deliver leading products that improve patient outcomes. We know we are successful when doctors and patients place their trust in our products and our company, when our employees excel and when our efforts make a meaningful difference in the lives of the patients and communities we serve.

Updates by Month

Click a year to expand/contract

Westport Chamber of Commerce ©

Admin